{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Plasma+sample+collection&page=5", "query": { "intervention": "Plasma sample collection", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 155, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Plasma+sample+collection&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Plasma+sample+collection&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-04T12:41:27.750Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04056247", "title": "Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stage IV Non-small Cell Lung Cancer", "Stage IV Malignant Melanoma", "Stage IV Small Cell Lung Cancer", "Stage III Unresectable Non-Small Cell Lung Cancer", "Stage IIIb-d Malignant Melanoma" ], "interventions": [ { "name": "Plasma sample collection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "OncoHost Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10000, "start_date": "2019-10-01", "completion_date": "2029-10-01", "has_results": false, "last_update_posted_date": "2026-10-19", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Jacksonville, Florida • Miami, Florida + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04056247" }, { "nct_id": "NCT01005030", "title": "Spectroscopy in Parkinson Disease", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Blood draw", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Molecular Biometrics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "46 Years", "maximum_age": null, "sex": "ALL", "summary": "46 Years and older" }, "enrollment_count": 500, "start_date": "2009-10", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2009-11-10", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01005030" }, { "nct_id": "NCT04058132", "title": "Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Sildenafil Citrate 50Mg Tab", "type": "DRUG" }, { "name": "functional Near-infrared Spectroscopy (fNIRS)", "type": "DEVICE" }, { "name": "Carbon Dioxide (CO2) 5%", "type": "OTHER" }, { "name": "Neuropsychological Assessments", "type": "OTHER" }, { "name": "Gadolinium contrast infusion", "type": "DRUG" }, { "name": "Blood sample collection for research purposes", "type": "PROCEDURE" }, { "name": "Structural brain Magnetic Resonance Imaging (MRI", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DEVICE", "OTHER", "PROCEDURE" ], "sponsor": "Uniformed Services University of the Health Sciences", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 1, "start_date": "2019-08-09", "completion_date": "2020-03-01", "has_results": false, "last_update_posted_date": "2024-02-28", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04058132" }, { "nct_id": "NCT06532279", "title": "Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Head and Neck Squamous Cell Carcinoma", "Hypopharyngeal Squamous Cell Carcinoma", "Laryngeal Squamous Cell Carcinoma", "Nasopharyngeal Squamous Cell Carcinoma", "Oral Cavity Squamous Cell Carcinoma", "Oropharyngeal Squamous Cell Carcinoma", "Stage 0 Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage 0 Hypopharyngeal Carcinoma AJCC v8", "Stage 0 Nasopharyngeal Carcinoma AJCC v8", "Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage I Hypopharyngeal Carcinoma AJCC v8", "Stage I Laryngeal Cancer AJCC v8", "Stage I Lip and Oral Cavity Cancer AJCC v8", "Stage I Nasopharyngeal Carcinoma AJCC v8", "Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage II Hypopharyngeal Carcinoma AJCC v8", "Stage II Laryngeal Cancer AJCC v8", "Stage II Lip and Oral Cavity Cancer AJCC v8", "Stage II Nasopharyngeal Carcinoma AJCC v8", "Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage III Hypopharyngeal Carcinoma AJCC v8", "Stage III Laryngeal Cancer AJCC v8", "Stage III Lip and Oral Cavity Cancer AJCC v8", "Stage III Nasopharyngeal Carcinoma AJCC v8", "Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVA Hypopharyngeal Carcinoma AJCC v8", "Stage IVA Laryngeal Cancer AJCC v8", "Stage IVA Lip and Oral Cavity Cancer AJCC v8", "Stage IVA Nasopharyngeal Carcinoma AJCC v8", "Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVB Hypopharyngeal Carcinoma AJCC v8", "Stage IVB Laryngeal Cancer AJCC v8", "Stage IVB Lip and Oral Cavity Cancer AJCC v8", "Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stomatitis" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Image Guided Radiation Therapy", "type": "RADIATION" }, { "name": "Intensity-Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "MnSOD Mimetic BMX-001", "type": "DRUG" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE", "DRUG", "RADIATION" ], "sponsor": "NRG Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 98, "start_date": "2025-06-23", "completion_date": "2032-01-01", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 153, "location_summary": "Gilbert, Arizona • Peoria, Arizona • Phoenix, Arizona + 126 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Surprise", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06532279" }, { "nct_id": "NCT01144507", "title": "Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cystic Fibrosis", "Pancreatic Insufficiency" ], "interventions": [ { "name": "Abdominal Ultrasound", "type": "PROCEDURE" }, { "name": "Sample collection procedures", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "3 Years to 12 Years" }, "enrollment_count": 774, "start_date": "2010-01-12", "completion_date": "2023-06-14", "has_results": false, "last_update_posted_date": "2025-04-11", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 10, "location_summary": "Aurora, Colorado • Atlanta, Georgia • Chicago, Illinois + 7 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01144507" }, { "nct_id": "NCT07226466", "title": "Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Brain Tumor Adult", "Brain Metastases From Solid Tumors", "Brain Tumor, Primary", "Brain Tumor" ], "interventions": [ { "name": "Blood sample", "type": "PROCEDURE" }, { "name": "Brain magnetic resonance imaging (MRI)", "type": "PROCEDURE" }, { "name": "Brain Health Assessment", "type": "PROCEDURE" }, { "name": "Quality of Life (QoL) Questionnaire", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "RADIATION" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2026-12-15", "completion_date": "2029-02-28", "has_results": false, "last_update_posted_date": "2026-10-29", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07226466" }, { "nct_id": "NCT06568172", "title": "Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Eyelid Squamous Cell Carcinoma", "Recurrent Eyelid Squamous Cell Carcinoma", "Recurrent Skin Acantholytic Squamous Cell Carcinoma", "Recurrent Skin Clear Cell Squamous Cell Carcinoma", "Recurrent Skin Lymphoepithelial Carcinoma", "Recurrent Skin Spindle Cell Squamous Cell Carcinoma", "Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation", "Resectable Eyelid Squamous Cell Carcinoma", "Resectable Skin Acantholytic Squamous Cell Carcinoma", "Resectable Skin Clear Cell Squamous Cell Carcinoma", "Resectable Skin Lymphoepithelial Carcinoma", "Resectable Skin Spindle Cell Squamous Cell Carcinoma", "Resectable Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation", "Skin Acantholytic Squamous Cell Carcinoma", "Skin Clear Cell Squamous Cell Carcinoma", "Skin Lymphoepithelial Carcinoma", "Skin Spindle Cell Squamous Cell Carcinoma", "Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation", "Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cemiplimab", "type": "BIOLOGICAL" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Image Guided Radiation Therapy", "type": "RADIATION" }, { "name": "Intensity-Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Surgical Procedure", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "BIOLOGICAL", "RADIATION", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 420, "start_date": "2025-02-18", "completion_date": "2031-08-14", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 196, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • Phoenix, Arizona + 147 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06568172" }, { "nct_id": "NCT01060371", "title": "Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia Type 2", "Spinocerebellar Ataxia Type 3", "Spinocerebellar Ataxia Type 6", "Spinocerebellar Ataxia Type 7", "Spinocerebellar Ataxia Type 8", "Spinocerebellar Ataxia Type 10", "RFC1 Gene Mutation", "Spinocerebellar Ataxia Type 27b", "Healthy Participants" ], "interventions": [ { "name": "Genetic Testing", "type": "GENETIC" }, { "name": "Blood Collection", "type": "OTHER" }, { "name": "Magnetic Resonance Imaging (MRI) Scan", "type": "OTHER" }, { "name": "Assessments and Questionnaires", "type": "OTHER" }, { "name": "Cerebrospinal Fluid Collection", "type": "OTHER" } ], "intervention_types": [ "GENETIC", "OTHER" ], "sponsor": "Lauren Moore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 1400, "start_date": "2010-04", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2026-08-03", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 16, "location_summary": "Los Angeles, California • San Francisco, California • Gainesville, Florida + 12 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01060371" }, { "nct_id": "NCT07089836", "title": "This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Treponema Pallidum", "Treponema Pallidum Infection", "Syphilis Infection", "Serum", "Plasma", "Blooddraw", "Sexually Transmitted Infection (STI)" ], "interventions": [ { "name": "ALPCO Syphilis-T", "type": "DEVICE" }, { "name": "ALPCO Syphilis-NT CLIA Kits", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "American Laboratory Products Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 1000, "start_date": "2025-12-10", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 6, "location_summary": "Lancaster, California • Los Angeles, California • North Miami, Florida + 3 more", "locations": [ { "city": "Lancaster", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "North Miami", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07089836" }, { "nct_id": "NCT00855556", "title": "Parkinson's Disease Genetics Database", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "blood draw", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2008-02", "completion_date": "2013-02", "has_results": false, "last_update_posted_date": "2015-09-16", "last_synced_at": "2026-11-04T12:41:27.750Z", "location_count": 1, "location_summary": "Manhasset, New York", "locations": [ { "city": "Manhasset", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00855556" } ] }